Semaglutide 2mg — Vial Spec, Reconstitution Math & COA

A 2mg vial of semaglutide provides a precise mass of lyophilized peptide optimized for acute in vitro binding assays and localized preclinical rodent cohorts. Laboratory investigators frequently select this specific fill mass to ensure complete peptide utilization within established stability windows without risking contamination or degradation from repeated ambient exposure.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

A 2mg vial of semaglutide provides a precise mass of lyophilized peptide optimized for acute in vitro binding assays and localized preclinical rodent cohorts. Laboratory investigators frequently select this specific fill mass to ensure complete peptide utilization within established stability windows without risking contamination or degradation from repeated ambient exposure.

Reviewed by PX1 Research scientific team

Key takeaways

  • The [semaglutide](/research-peptides/semaglutide) 2mg vial is formulated as a lyophilized, vacuum-sealed solid containing 2.0 milligrams of high-purity synthetic glucagon-like peptide-1 (GLP-1) receptor agonist.
  • PX1 Research manufactures and distributes high-purity research compounds strictly engineered for rigorous laboratory investigation.
  • Accurate concentration calculations are vital for reproducible volumetric pipetting.
  • Repeated freeze-thaw cycles cause structural degradation and physical aggregation of synthetic peptide chains.

Semaglutide 2mg Vial Specification & Experimental Applications

The semaglutide 2mg vial is formulated as a lyophilized, vacuum-sealed solid containing 2.0 milligrams of high-purity synthetic glucagon-like peptide-1 (GLP-1) receptor agonist. Packaged in USP Type I borosilicate glass vials with rubber stoppers and aluminum flip-off caps, this specific unit size maintains compound integrity against gas permeation and moisture degradation during long-term cold storage.

In laboratory settings, the 2mg fill mass serves as a versatile baseline for pilot feasibility studies, cell-culture receptor binding kinetics, and short-duration rodent animal models. By utilizing a 2mg mass, research facilities can limit the operational overhead associated with aliquoting higher-volume reconstituted batches, ensuring that reconstituted solution is consumed within optimal stability parameters.

PX1 Research Catalog Availability & Mass Configurations

PX1 Research manufactures and distributes high-purity research compounds strictly engineered for rigorous laboratory investigation. While individual 2mg vials represent a common request for targeted pilot protocols, PX1 Research maintains flexible catalog inventory including various unit masses across our complete research peptide catalog.

If a specific protocol requires larger unit volumes—such as 5mg or 10mg vials—or custom batch packaging for high-throughput screening, principal investigators can evaluate our standard catalog offerings or arrange institutional procurement through our dedicated support channels.

Reconstitution Mathematics for 2mg Lyophilized Mass

Accurate concentration calculations are vital for reproducible volumetric pipetting. When reconstituting a 2mg semaglutide lyophilized cake, the final concentration ($µg/µL$ or $mg/mL$) depends directly on the volume of diluent introduced into the vial. Standard laboratory diluents include Bacteriostatic Water (0.9% benzyl alcohol) or Sterile 0.9% Normal Saline for immediate assay execution.

Below are the primary concentration conversions when reconstituting a 2mg (2,000 µg) vial:

• 1.0 mL Diluent Addition: $2.0\text{ mg} / 1.0\text{ mL} = 2.0\text{ mg/mL}$ (or $2.0\text{ }\mu\text{g/}\mu\text{L}$). Every $100\mu\text{L}$ drawn yields $200\mu\text{g}$ of active compound.

• 2.0 mL Diluent Addition: $2.0\text{ mg} / 2.0\text{ mL} = 1.0\text{ mg/mL}$ (or $1.0\text{ }\mu\text{g/}\mu\text{L}$). Every $100\mu\text{L}$ drawn yields $100\mu\text{g}$ of active compound.

• 3.0 mL Diluent Addition: $2.0\text{ mg} / 3.0\text{ mL} = 0.667\text{ mg/mL}$ (or $0.67\text{ }\mu\text{g/}\mu\text{L}$). Every $100\mu\text{L}$ drawn yields $66.7\mu\text{g}$ of active compound.

Reconstitution should be conducted using sterile lab technique: direct the stream of diluent down the glass wall of the vial rather than directly onto the lyophilized cake. Allow the cake to passively dissolve over 5–10 minutes without aggressive agitation or vortexing to prevent protein shearing and foam formation. For rapid multi-concentration calculations, utilize our interactive reconstitution calculator.

Aliquot Planning & Volumetric Pipetting Protocols

Repeated freeze-thaw cycles cause structural degradation and physical aggregation of synthetic peptide chains. Once a 2mg semaglutide vial has been reconstituted, laboratory technicians should immediately divide the working solution into single-use micro-aliquots using sterile, low-binding polypropylene micro-centrifuge tubes.

Aliquots intended for downstream use over several weeks should be transferred to $-80^\circ\text{C}$ storage, while working aliquots in active use can be stored at $2^\circ\text{C}$ to $8^\circ\text{C}$ for up to 28 days when reconstituted with preserved diluent. Detailed handling procedures and environmental controls are outlined in our dedicated peptide storage protocols guide.

Biochemical Mechanism & Receptor Activation in Preclinical Models

Semaglutide is a modified 31-amino acid peptide analog of endogenous GLP-1 (7-37), featuring two key structural modifications: an amino acid substitution at position 8 (AIB) to confer resistance to dipeptidyl peptidase-4 (DPP-4) cleavage, and a $C_{18}$ fatty diacid chain attached via a spacer at position 26 to facilitate albumin binding. Preclinical studies suggest these modifications significantly extend the terminal elimination half-life in rodent and non-human primate models.

In vitro functional assays demonstrate that semaglutide acts as a potent agonist at the GLP-1 receptor, activating membrane-bound adenylate cyclase to stimulate intracellular cyclic AMP (cAMP) accumulation. In cell-based binding assays, semaglutide displays sub-nanomolar receptor affinity ($EC_{50} \approx 0.38\text{ nM}$). Researchers evaluating metabolic signaling cascades often compare GLP-1 activity against related gut peptide receptors, such as those targeted by GLP2-T peptide or combined multi-receptor agonists.

Quality Assurance: HPLC Purity, Mass Spectrometry & Endotoxin Testing

Analytical consistency is critical for high-impact research. Every lot of semaglutide distributed by PX1 Research undergoes strict analytical testing performed by independent ISO 17025 accredited testing laboratories.

Quality verification standards for each lot include:

• High-Performance Liquid Chromatography (HPLC): Confirms peptide purity levels exceeding 99.0%, identifying and quantifying minor baseline impurities.

• Mass Spectrometry (MS): Verifies the exact molecular mass (4113.58 Da) to ensure proper primary sequence synthesis.

• Limulus Amebocyte Lysate (LAL) Assay: Quantifies bacterial endotoxin levels to guarantee limits below 0.05 EU/mg, preventing lipopolysaccharide-induced inflammatory interference in delicate in vitro and animal assays.

Principal investigators can review and download lot-matched documentation prior to testing using our public COA verification portal.

Comparative Analysis: Selecting the Optimal Peptide Class & Vial Mass

Choosing between a 2mg semaglutide vial and other metabolic research peptides depends on experimental design, cohort scale, and target receptor pathways. While semaglutide provides selective GLP-1 receptor activation, contemporary metabolic research frequently evaluates dual or triple receptor agonists to examine synergistic metabolic pathways.

For instance, investigators conducting comparative studies may evaluate single-target GLP-1 signaling alongside dual GLP-1/GIP agonists like tirzepatide research compound, triple GLP-1/GIP/glucagon co-agonists like retatrutide, or non-incretin selective agents such as the amylin receptor agonist cagrilintide. Evaluating these distinct molecular profiles allows laboratories to construct comprehensive comparative matrices across diverse preclinical models.

Storage Guidelines & Lyophilized Cake Preservation

Unreconstituted semaglutide 2mg vials should be kept in cold, dry conditions protected from ambient light. Long-term storage at $-20^\circ\text{C}$ or $-80^\circ\text{C}$ preserves chemical stability for up to 24 months from the manufacturing date. Vials stored short-term at standard refrigeration temperatures ($2^\circ\text{C}$ to $8^\circ\text{C}$) remain stable for up to 90 days if unopened and desiccated.

Allow lyophilized vials to reach room temperature before inserting a needle for reconstitution. This prevents thermal shock and condensation formation within the container closure system. For full storage specifications across various peptide classes, review the technical documentation available in our PX1 research library.

Institutional Procurement & Laboratory Supply Chain Support

PX1 Research maintains streamlined procurement pipelines for university laboratories, biotechnology enterprises, and contract research organizations (CROs). Operating from primary fulfillment hubs in California and Arizona, PX1 offers same-day dispatch for all institutional orders placed Monday through Friday prior to 12:00 PM PST.

Laboratories seeking multi-vial allocations, recurring shipment schedules, or volume tier discounts can establish a verified institutional account through our wholesale procurement platform.

Frequently Asked Questions

What is the concentration of a semaglutide 2mg vial after adding 2mL of bacteriostatic water?

Adding 2.0 mL of bacteriostatic water to a 2mg lyophilized cake yields a final solution concentration of 1.0 mg/mL (1.0 µg/µL). In this concentration, a 100 µL volumetric draw contains 100 µg of semaglutide.

Does PX1 Research provide lot-specific COAs for 2mg semaglutide vials?

Yes. Every batch distributed by PX1 Research is paired with a lot-matched Certificate of Analysis (COA) from an independent ISO 17025 accredited testing facility, detailing HPLC purity, mass spectrometry mass verification, and LAL endotoxin levels.

How long does reconstituted semaglutide remain stable at 2°C to 8°C?

When reconstituted with preserved Bacteriostatic Water (0.9% benzyl alcohol), semaglutide solutions maintain chemical stability for up to 28 days under strict refrigeration (2°C to 8°C). Avoid repeated ambient temperature cycles.

What are the endotoxin limits for PX1 semaglutide research compounds?

All semaglutide lots pass Limulus Amebocyte Lysate (LAL) testing with endotoxin levels strictly controlled below 0.05 EU/mg, preventing endotoxin-mediated immune responses in cellular or animal assays.

Why select a 2mg semaglutide vial over a 5mg or 10mg vial?

A 2mg vial mass is optimal for pilot studies, short assay series, or small rodent cohorts. It allows researchers to use reconstituted solution fully within its stability window without leaving residual liquid subject to degradation.

Can reconstituted semaglutide 2mg solution be frozen?

Yes, but only in single-use micro-aliquots. Freezing the reconstituted solution at -80°C preserves structural integrity, provided the solution is thawed only once immediately prior to assay administration.

What diluent is recommended for reconstituting semaglutide for in vitro assays?

For immediate in vitro cellular assays, sterile phosphate-buffered saline (PBS) or sterile standard saline is often preferred. For multi-day preclinical animal protocols, Bacteriostatic Water containing 0.9% benzyl alcohol is recommended to inhibit microbial growth.

Are PX1 Research compounds intended for human or veterinary use?

No. All products supplied by PX1 Research are sold strictly as research compounds for in vitro and laboratory investigation only. They are not for human, clinical, or veterinary diagnostic or therapeutic applications.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.